PPAR AGONISTS

PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly...

Full description

Saved in:
Bibliographic Details
Main Author CHERYL MYERS HAYWARD
Format Patent
LanguageEnglish
Spanish
Published 04.12.2003
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans.
Bibliography:Application Number: MX2003PA07284